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ABSTRACT
Reactions of 5-methylisoxazol-3-amine with diethyl ethoxymethylenemalonate derivatives are described. By this method ethyl




Pyrimidine and fused heterocyclic pyrimidine derivatives
are known to be associated with a wide spectrum of biological
activity.1–6 Isoxazolo[5,4-d]pyrimidines have received consider-
able attention due to their pharmacological applications as
antibacterial, antifungal, antimicrobial, anti-inflammatory and
anticancer agents.7–10 Aminoisoxazole derivatives are widely
used with different active methylene compounds for preparing
new heterocyclic compounds.5,6,11–14
In this work, we describe the synthesis of ethyl 2-methyl-7-
oxo-7H-isoxazolo[2,3-a]pyrimidine-6-carboxylate derivatives
from 5-methylisoxazol-3-amine and diethyl ethoxymethyl-
enemalonate derivatives.
2. Results and Discussion
The reaction of 5-methylisoxazol-3-amine with diethyl
ethoxymethylenemalonate derivatives in dry xylene under
reflux conditions gives exclusively the corresponding ethyl
2-methyl-7-oxo-7H-isoxazolo[2,3-a]pyrimidine-6-carboxylate 2
(Scheme 1) in good yield after purification by column chroma-
tography (Table 1). This reaction is mainly condensation followed
by cyclization. Initially the NH2 group of 5-methylisoxazol-3-
amine attacks the carbon attached to the ethoxy group of diethyl
ethoxymethylenemalonate, which is prone to nucleophilic
attack. The cyclization proceeds at the ester carbonyl (CO2Et)
function to give products 2.
Using absolute ethanol as a solvent under reflux, the conden-
sation of 5-methylisoxazol-3-amine with diethyl ethoxymethyl-
enemalonate derivatives gives exclusively the intermediates 1 in
high yield (Table 1). Compounds 2 can be obtained from the
enamines 1 by reflux in dry xylene, but the yields are lower.
Formation of the ethyl 2-methyl-7-oxo-7H-isoxazolo[2,3-a]
pyrimidine-6-carboxylate structure 2 can be discussed via
intramolecular cyclization of the intermediate 1 via EtOH elimi-
nation (Scheme 2).
In conclusion, new ethyl 2-methyl-7-oxo-7H-isoxazolo-
[2,3-a]pyrimidine-6-carboxylate derivatives were prepared and
characterized. The biological activity of the products is under
investigation.
3. Experimental
The 1H and 13C NMR spectra were recorded on a Bruker AC 300
(Wissembourg Cedex, France) at 300 and 75 MHz respectively.
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Scheme  1.
Synthesis of isoxazolopyrimidine.
TMS was used as standard reference for 1H and 13C NMR spectra.
Melting points were determined in capillaries and they are
uncorrected. IR spectra were recorded on a Bruker IFS 66V/S
spectrometer (Bioaccess, Les Berges du Lac, Tunisia). Mass spec-
tra were determined on a GCMS-QP 1000 EX instrument
(Champs Sur Marne, France) at 70 eV (EI). Silica gel 60 (Merck)
was used for chromatographic column separations.
3.1. Preparation of Diethyl 2-((5-methylisoxazol-3-
ylamino)methylene)malonate (1a)
A solution of 5-methylisoxazol-3-amine (0.49 g, 5 mmol) and
diethyl ethoxymethylenemalonate (1.08 g, 5 mmol) in absolute
ethanol (20 mL) was refluxed for 6 h. The mixture was cooled, the
solid was filtered and recrystallized from ethanol.
δH (300 MHz, CDCl3): 1.35 (6H, m, 2CH3CH2O), 2.40 (3H, s, CH3),
4.25 (4H, m, 2CH3CH2O), 5.90 (1H, s, CH=C-O), 8.45 (1H, d, J
13.78 Hz, CH=C) and 10.70 ppm (1H, d, J 13.78 Hz, NH);
δC (75 MHz, CDCl3): 12.52, 13.87 (2C, 2CH3CH2O), 14.07 (CH3),
60.24, 60.62 (2C, 2CH3CH2O), 95.05 (CH=CO), 150.90 (CH=C),
151.53 (CH=C-O), 159.14 (CH=C), 164.60 (N-C=N), 168.15 and
171.16 ppm (2C, 2C=O); νmax: 3240 (NH) and 1700 cm
–1 (C=O);
MS (EI): m/z 268 (M+), 222, 177, 162, 134 and 120.
3.2. Preparation of Enamines 1b–d: General Procedure
A solution of 5-methylisoxazol-3-amine (0.49 g, 5 mmol) and
diethyl ethoxymethylenemalonate derivative (5 mmol) in absolute
ethanol (20 mL) was refluxed for 36 h. The solvent was removed
and the residue was purified by column chromatography over
silica gel (eluent: ethyl acetate/cyclohexane: 1/5) to obtain 1b–d.
3.2.1. Diethyl 2-(1-(5-methylisoxazol-3-ylamino)ethylidene)malonate
(1b)
δH (300 MHz, CDCl3): 1.30 (6H, m, 2CH3CH2O), 2.30 (3H, s,
CH3C=C), 2.45 (3H, s, CH3C-O), 4.20 (4H m, 2CH3CH2O), 5.90
(1H, s, CH=C-O) and 11.30 ppm (1H, s, NH); δC (75 MHz, CDCl3):
12.45 and 13.64 (2C, 2CH3CH2O), 14.03 (CH3C), 24.00 (CH3C=C),
60.20, 60.32 (2C, 2CH3CH2O), 97.15 (CH=CO), 151.53 (CH=C),
151.58 (CH=C-O), 158.90 (CH=C), 164.34 (N-C=N), 168.03 and
171.06 ppm (2C, 2C=O); νmax: 3238 (NH) and 1700 cm
–1 (C=O);
MS (EI): m/z 282 (M+), 209, 164 and 135.
3.2.2. Diethyl 2-(1-(5-methylisoxazol-3-
ylamino)propylidene)malonate (1c)
δH (300 MHz, CDCl3): 1.22 (3H, t, J 7.42 Hz, CH3CH2), 1.31 (6H,
m, 2CH3CH2O), 2.40 (3H, s, CH3C-O), 2.60 (2H, q, J 7.42 Hz,
CH3CH2), 4.24 (4H, m, 2CH3CH2O), 5.72 (1H, s, CH=C-O) and
10.10 ppm (1H, s, NH); δC (75 MHz, CDCl3): 12.25, 13.10 (2C,
2CH3CH2O), 12.50 (CH3CH2C), 14.21 (CH3C), 26.55 (CH3CH2C),
60.35, 60.45 (2C, 2CH3CH2O), 98.04 (CH=CO), 150.10 (CH=C),
151.51 (CH=C-O), 159.07 (CH=C), 163.50 (N-C=N), 167.58 and
170.70 ppm (2C, 2C=O); νmax: 3236 (NH) and 1700 cm
–1 (C=O);
MS (EI): m/z 296 (M+), 223, 178 and 149.
3.2.3. Diethyl 2-(1-(5-methylisoxazol-3-
ylamino)(phenyl)methylene)malonate (1d)
δH (300 MHz, CDCl3): 1.21 (6H, m, 2CH3CH2O), 2.41 (3H, s, CH3),
4.20 (4H, m, 2CH3CH2O), 5.91 (1H, s, CH=C-O), 7.50 (5H, m,
ArH) and 11.30 ppm (1H, s, NH); δC (75 MHz, CDCl3): 12.30, 12.87
(2C, 2CH3CH2O), 14.50 (CH3C), 60.45, 60.50 (2C, 2CH3CH2O),
96.71 (CH=CO), 128.40, 130.81, 131.10, 136.24 (6C, ArC), 151.52
(CH=C-O), 157.55 (C6H5C=C), 159.14 (CH=C), 166.08 (N-C=N),
167.20 and 170.54 ppm (2C, 2C=O); νmax: 3242 (NH) and 1700 cm
–1
(C=O); MS (EI): m/z 344 (M+), 271, 126.
3.3. Preparation of Isoxazolopyrimidines 2:
General Procedure
A solution of 5-methylisoxazol-3-amine (0.49 g, 5 mmol) and
diethyl ethoxymethylenemalonate derivative (5 mmol) in dry
xylene (20 mL) was refluxed for 48 h. The solvent was removed
and the residue was purified by column chromatography over
silica gel (eluent: ethyl acetate/cyclohexane: 1/3) to obtain 2.
3.3.1. Ethyl 2-methyl-7-oxo-7H-isoxazolo[2,3-a]pyrimidine-6-
carboxylate (2a)
δH (300 MHz, CDCl3): 1.32 (3H, t, J 7.18 Hz, CH3CH2O), 2.40 (3H,
s, CH3), 4.20 (2H q, J 7.18 Hz, CH3CH2O), 6.35 (1H, s, CH=C-O)
and 8.26 ppm (1H, s, CH=C); δC (75 MHz, CDCl3): 12.10 (1C,
CH3CH2O), 14.19 (CH3C), 61.68 (1C, CH3CH2O), 99.78
(CH=C-O), 111.74 (CH=C), 150.90 (CH3C), 153.46 (CH=C),
165.28 (N-C=N), 165.60 (N-C=O), and 168.23 ppm (CO); νmax:




δH (300 MHz, CDCl3): 1.31 (3H, q, J 7.18 Hz, CH3CH2O), 2.41 (s,
3H, CH3CO), 2.51 (s, 3H,CH3C=C), 4.20 (2H, q, J 7.18 Hz,
CH3CH2O) and 6.35 ppm (1H, s, CH=C-O); δC (75 MHz, CDCl3):
12.10 (CH3CH2O), 14.52 (CH3C-O), 26.90 (CH3C=C), 60.68
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Table 1 Reaction times, yields and melting points of compounds 1 and 2.
Compound R Reaction time/h Yield/% M.p./C
1a H 6 95 114
1b CH3 36 87 Oil
1c C2H5 36 82 Oil
1d C6H5 36 78 Oil
2a H 48 68 145
2b CH3 48 85 176
2c C2H5 48 88 214
2d C6H5 48 80 217
Scheme 2.
Intramolecular cyclization of 1.
(CH3CH2O), 99.78 (CH=C-O), 111.74 (CH=C), 150.90 (CH3C),
153.46 (CH=C), 165.28 (N-C=N), 165.60 (N-C=O) and
168.23 ppm (CO); νmax: 1680 (C=O) and 1738 cm
–1 (C=O ester);
MS (EI): m/z 236 (M+), 191, 177 and 123.
3.3.3. Ethyl 5-ethyl-2-methyl-7-oxo-7H-isoxazolo[2,3-a]pyrimi-
dine-6-carboxylate (2c)
δH (300 MHz, CDCl3): 1.20 (3H, t, J 7.50 Hz, CH3CH2), 1.30 (3H, t,
J 7.18 Hz, CH3CH2O), 2.55 (s, 3H, CH3), 2.71 (2H, q, J 7.50 Hz,
CH3CH2), 4.21 (2H, q, J 7.18 Hz, CH3CH2O) and 6.36 ppm (1H, s,
CH=C-O); δC (75 MHz, CDCl3): 12.93 (CH3CH2O), 13.11
(CH3C=C), 14.17 (CH3C), 29.88 (CH3CH2C), 61.73 (CH3CH2O),
99.84 (CH=C-O), 111.67 (CH=C), 151.13 (1C, CH3C), 153.76
(CH=C), 165.26 (N-C=N), 168.00 (N-C=O) and 169.67 ppm
(CO); νmax: 1680 (C=O) and 1736 cm
–1 (C=O ester); MS (EI): m/z
250 (M+), 204, 183 and 137.
3.3.4. Ethyl 2-methyl-7-oxo-5-phenyl-7H-isoxazolo[2,3-a]pyrimidine-
6-carboxylate (2d)
δH (300 MHz, CDCl3): 1.05 (3H, t, J 7.18 Hz, CH3CH2O), 2.55 (3H,
s, 3H, CH3), 4.15 (2H q, J 7.18 Hz, CH3CH2O), 6.41 (1H, s, CHC-O)
and 7.51 ppm (5H, m, ArH); δC (75 MHz, CDCl3): 13.06
(CH3CH2O), 13.63 (CH3), 61.70 (CH3CH2O), 100.26 (CH=C-O),
112.05 (CH=C), 128.02, 128,41, 129,97,138.08 (6C, ArC), 151.20
(CH3C), 153.61 (CH=C), 163.94 (N-C=N), 165.61 (N-C=O) and
168.37 ppm (CO); νmax: 1680 (C=O) and 1740 cm
–1 (C=O ester);
MS (EI): m/z 298 (M+), 253, 226 and 182.
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